Business Wire

Legerity FastPost Helps Leading Life Insurer to Automate New Financial Reporting and Disclosures Process

Share

Aegon UK, a leading savings, protection and investment service provider has selected Legerity Limited’s FastPost IFRS 17 solution to help it transition to the new International Financial Reporting Standard (IFRS 17). The new standard takes effect from January 2022 and is one of the most significant changes to accounting in the insurance sector in years,

Legerity will provide Aegon UK with its third generation FastPost Accounting Rules and Sub-Ledger solution for implementation as an integrated part of its overall IFRS 17 accounting and reporting process.

David Wilson, IFRS 17 Programme Director at Aegon UK, comments, “IFRS 17 is a complex standard impacting multiple stakeholders including Actuarial, Finance and IT. There is no one size fits all solution for IFRS 17 so it is important that we selected best in class technology that can seamlessly integrate into our end to end financial reporting solution. After a detailed market and product evaluation process we have selected Legerity FastPost. We have been greatly impressed by the Legerity team and their FastPost accounting rules and sub-ledger technology.”

Legerity FastPost has also been selected by other Aegon regions for implementation as part of the Aegon Group’s IFRS 17 global programme.

Jeremy Wood, CEO and Founder of Legerity, adds “We are delighted to have entered into this agreement to be a key solution provider to Aegon’s future financial reporting. Aegon is a forward looking firm committed to market innovation and a digital future. It is great testament to our technology, team and achievements to have been selected by Aegon”.

Notes to Editors

About Aegon

• In the UK, Aegon offers retirement, workplace savings and protection solutions to well over three million customers and employs approximately 3,450 staff. More information: www.aegon.co.uk

• As an international life insurance, pensions and asset management group based in The Hague, Aegon has businesses in over twenty five markets in the Americas, Europe and Asia. Aegon companies employ over 28,000 people and have millions of customers across the globe. Further information: www.aegon.com

About Legerity

Legerity helps clients deliver complex accounting change. Legerity’s FastPost Accounting Rules platform provides a 3rd generation solution that meets the new IFRS 9, 15, 16 and 17 accounting standards in a fast and non-disruptive manner.

IFRS 17 is an opportunity to go beyond just compliance. Legerity FastPost standardises data across the enterprise to deliver real benefits: simplified processing, improved reporting, faster close, reduced cost and future-proof scalability.

Available as a SaaS cloud-based fully managed service, FastPost provides highly scalable and on demand performance, giving firms’ confidence that IFRS accounting data is available when required.

For further information please visit www.legerityfinancials.com

Contact information

Jeremy Wood
CEO – Legerity Limited
Jeremy.wood@legerityfinancials.com
Tel: +44 (0)203 871 2944
Mob: +44 (0)7775 681478

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ADVA and PSNC showcase 1200G channel transmission at SC1919.11.2019 14:45:00 CETPress release

ADVA (FSE: ADV) today announced that it’s hosting a joint showcase with PSNC at SC19 that features the industry’s first 1200Gbit/s optical channel transmission. Built upon the ADVA FSP 3000 TeraFlex™ terminal, the demo underscores the power of adaptive technology to maximize bandwidth efficiency in any network scenario. Using fractional QAM capabilities to boost fiber utilization and channel capacity, the demo highlights how network operators and enterprises can cost-effectively inject capacity into their networks without major upgrades. At SC19, TeraFlex™ will carry 1200Gbit/s channels in a 150GHz window or 800Gbit/s channels in a 100GHz window, delivering an industry-leading spectral efficiency of 8bit/s/Hz. These figures set a new benchmark for a commercially available product. The ADVA FSP 3000 TeraFlex™ has now been shipping for several months. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005670/en/ The FSP 3000

Andersen Global Expands in Bosnia and Herzegovina19.11.2019 14:30:00 CETPress release

Andersen Global announces it has entered into a collaboration agreement with a full-service law firm in Bosnia and Herzegovina. Banja Luka-based SAJIĆ is the fourth firm in the region to sign a Collaboration Agreement with Andersen Global in the last month. Owner and Managing Partner Aleksandar Sajic founded the firm in 2003 and has expanded it to include four partners and nearly 20 professionals. SAJIĆ provides an array of legal services to clients including civil litigation, family law, corporate negotiations, intellectual property, science and technology, and tax. This collaboration expands Andersen Global’s coverage to include nearly 65 countries around the world with legal services in over 55 countries. “Collaborating with Andersen Global enhances our service offerings and extends our cross-border reach,” said Aleksandar. “The organization’s global platform allows us to expand our capabilities and bring the benefits of a global firm to our clients.” “The addition of SAJIĆ provides

Virgin Voyages Sets Sights on the Med for Second Ship ‘Valiant Lady’ Launching 3 Exhilarating 7-night Itineraries From Barcelona With Overnights in Ibiza19.11.2019 14:02:00 CETPress release

Virgin Voyages, the new lifestyle brand shaking up the travel industry, announced their second ship will be called ‘Valiant Lady’ and that she will sail 7-night Mediterranean itineraries out of Barcelona, Spain when she debuts in May 2021. Bookings for the three feature itineraries, that all offer overnight and late-night stops across some of the hottest destinations in France, Italy and Spain, will open December 19, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005362/en/ Virgin Voyages Sets Sights on the Med for Second Ship ‘Valiant Lady’ (Graphic: Business Wire) “We are thrilled to unveil the name of our second ship - Valiant Lady - and to deliver on our commitment to offer travelers a sea change in how they can experience cruising in this fantastic part of the world. Our Sailors will fall in love with the places we go and the moments and memories they will be able to create on our gorgeous ship. After all, t

Mary Kay Advocates for Global Female Empowerment, Entrepreneurship and Equality at Top Women’s Conferences Around the World19.11.2019 14:00:00 CETPress release

This month, Mary Kay Inc. continued to advocate for global female empowerment, entrepreneurship and equality by addressing the issues facing women today at top women’s conferences around the world. The company actively participated in two important international conferences: International Women’s Forum World Leadership Conference in Toronto, Canada, and the Reykjavik Global Forum – Women Leaders in Reykjavik, Iceland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005354/en/ L to R: Marijana Klapcic, Manager Communications, Public Relations & Creative Marketing, MK Canada; Pat Mitchell, author Becoming a Dangerous Woman; Michelle Haurilak, Director, Public Relations, Digital & Product Marketing, MK Canada (Photo: Mary Kay Inc.) “More than 56 years ago, Mary Kay Ash founded what is now one of the world’s leading corporate champions of female empowerment,” said Deb Gibbins, Chief Operating Officer of Mary Kay, Inc. “To h

TYAN Showcases HPC, AI and Storage Server Platforms Featuring 2nd Gen Intel® Xeon® Scalable Processors at SC1919.11.2019 14:00:00 CETPress release

TYAN®, an industry-leading server platform design manufacturer and a subsidiary of MiTAC Computing Technology Corporation, exhibits a broad selection of HPC, AI, storage and cloud server platforms that are optimized for enterprise and data center markets at SC19 through November 21st, Booth # 1601 in Denver’s Colorado Convention Center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005008/en/ TYAN HPC Server Platforms Boost Performance with 2nd Gen Intel Xeon Scalable Processors for Enterprises and Data Centers (Photo: Business Wire) “Data is the foundation of the new economy, and how organizations effectively move, store and process will help determine their level of success,” said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “By leveraging the 2nd gen Intel® Xeon® Scalable processors, TYAN’s leading portfolio of HPC, storage and cloud server platforms enable to help our c

Positive Pivotal Data for Daiichi Sankyo’s DS-8201 ([Fam]-Trastuzumab Deruxtecan) in Patients with HER2 Positive Metastatic Breast Cancer to be Presented at SABCS19.11.2019 14:00:00 CETPress release

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it will present new data across its investigational ADC portfolio at the 2019 San Antonio Breast Cancer Symposium (#SABCS19), December 10-14, 2019 in San Antonio, Texas. Positive data from the pivotal phase 2 DESTINY-Breast01 trial of DS-8201 ([fam-] trastuzumab deruxtecan), an investigational HER2 targeting antibody drug conjugate (ADC), will be unveiled, highlighting objective response rate, progression-free survival, duration of response and safety seen in patients with HER2 positive metastatic breast cancer previously treated with ado-trastuzumab emtansine. Trial-in-progress updates from the pivotal phase 3 development program of DS-8201 in patients with HER2 positive metastatic breast cancer, including a head-to-head study with ado-trastuzumab emtansine, and in patients with HER2 low metastatic breast cancer, also will be presented. An overview of the phase 1/2 trial for U3-1402, an investigational HE